Chemical formula: C₁₈H₂₃FINO₂ Molecular mass: 427.291 g/mol PubChem compound: 3086674
Ioflupane ¹²³I is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS).
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09AB03 | Iodine ioflupane (123I) | V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AB Iodine (123I) compounds |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DATSCAN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| STRIASCAN Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Ioflupane ¹²³I is an active ingredient of these brands:
United States (US)Cyprus (CY)Hong Kong (HK)Italy (IT)Japan (JP)Romania (RO)Singapore (SG)Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
